Impairment and recovery of CD8 T cell responses after sepsis

脓毒症后 CD8 T 细胞反应的受损和恢复

基本信息

  • 批准号:
    9128672
  • 负责人:
  • 金额:
    $ 30.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The ability to develop and sustain memory CD8 T cells post-infection or vaccination is a hallmark of the adaptive immune response and the basis for protective vaccination against infectious disease or in cancer immunotherapy. Since the degree of protection to infection depends on the functional characteristics (quality) and number (quantity) of memory CD8 T cells present at the time of antigen (Ag) re-exposure, understanding the mechanisms that govern naïve-to-memory CD8 T cell differentiation and long-term maintenance of the memory CD8 T cell pool are critical for achieving maximal protection. The outcome of viral or bacterial infections is determined by a series of complex interactions between the pathogen and infected host. Among these interactions the immune status of the host at the time of infection can have a major impact in the host susceptibility to disease. Polymicrobial sepsis represents a leading cause of death in most intensive care units, and patients who survive sepsis often display severely compromised immune function with deficits in innate and adaptive immune responses. One hallmark of the general immune suppression observed during polymicrobial sepsis is diminished T cell immunity. Consequently, septic patients and sepsis survivors are highly susceptible to new or previously encountered infections that are readily controlled by T cells when a normal, functioning immune system is present. In this regard, our recent papers revealed that sepsis significantly compromises the host's ability to mount optimal CD8 T cell responses to newly introduced Ag presented in the context of systemic and localized model infections. Our data in these publications also revealed a previously unappreciated role for sepsis in shaping the quantity and functionality of infection- or vaccine-induced pre-existing memory CD8 T cells. However, the extent of sepsis-induced changes the naïve and memory CD8 T cell pool and mechanisms that control their recovery, long-term maintenance and differentiation as well as potential therapeutic interventions to restore number and/or function of naïve and memory CD8 T cells in sepsis survivors are currently unknown. Thus, our long-term goal is to fully understand the functional consequences imposed on naïve and pre-existing memory CD8 T cell populations following sepsis induction. Our central hypothesis is that sepsis-induced apoptosis of Ag-specific naïve and/or memory CD8 T cells leads to long-lasting deleterious changes in the composition and/or function of CD8 T cell responses that ultimately result in diminished CD8 T cell responses to newly or previously encountered Ag delivered in the context of localized and systemic infections. We will address our long-term goal with the following specific aims: Aim 1 - Define the regulatory role of dendriti cells in sepsis-induced impairment of CD8 T cell immunity to newly introduced antigens. Aim 2 - Determine the extent to which CD8 T cell intrinsic factors control primary CD8 T cell responses after sepsis. Aim 3 - Determine the impact of sepsis on maintenance and function of pre-existing memory CD8 T cell responses.
 描述(由申请方提供):感染或接种后形成和维持记忆性CD 8 T细胞的能力是适应性免疫应答的标志,也是针对感染性疾病或癌症免疫治疗的保护性疫苗接种的基础。由于对感染的保护程度取决于抗原(Ag)再暴露时存在的记忆性CD 8 T细胞的功能特征(质量)和数量(数量),因此了解控制幼稚至记忆性CD 8 T细胞分化的机制以及记忆性CD 8 T细胞库的长期维持对于实现最大保护至关重要。病毒或细菌感染的结果是由病原体和受感染宿主之间的一系列复杂相互作用决定的。在这些相互作用中,宿主在感染时的免疫状态可以对宿主对疾病的易感性产生重大影响。在大多数重症监护病房中,多微生物败血症是死亡的主要原因,败血症存活的患者通常表现出严重受损的免疫功能,先天性和适应性免疫应答不足。在多微生物脓毒症期间观察到的一般免疫抑制的一个标志是T细胞免疫力降低。因此,脓毒症患者和脓毒症幸存者非常容易受到新的或以前遇到的感染,当存在正常的功能性免疫系统时,这些感染很容易被T细胞控制。在这方面,我们最近的论文表明,败血症显着损害了宿主的能力, 在系统性和局部模型感染的背景下,对新引入的Ag产生最佳的CD 8 T细胞应答。我们在这些出版物中的数据还揭示了脓毒症在影响感染的数量和功能方面的一个以前未被认识到的作用, 疫苗诱导的预先存在的记忆性CD 8 T细胞。然而,脓毒症诱导的幼稚和记忆性CD 8 T细胞库变化的程度,控制其恢复、长期维持和分化的机制,以及恢复脓毒症幸存者中幼稚和记忆性CD 8 T细胞数量和/或功能的潜在治疗干预目前尚不清楚。因此,我们的长期目标是充分了解脓毒症诱导后对幼稚和预先存在的记忆CD 8 T细胞群的功能影响。我们的中心假设是,脓毒症诱导的Ag特异性幼稚和/或记忆CD 8 T细胞的凋亡导致CD 8 T细胞应答的组成和/或功能的长期有害变化,最终导致CD 8 T细胞对局部和全身感染背景下递送的新的或先前遇到的Ag的应答减少。我们将解决我们的长期目标与以下具体目标:目标1 -定义树突状细胞在脓毒症诱导的CD 8 T细胞免疫力受损的调节作用,以新引入的抗原。目的2 -确定脓毒症后CD 8 T细胞内在因子控制原发性CD 8 T细胞应答的程度。目的3 -确定脓毒症对预先存在的记忆性CD 8 T细胞应答的维持和功能的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VLADIMIR P BADOVINAC其他文献

VLADIMIR P BADOVINAC的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VLADIMIR P BADOVINAC', 18)}}的其他基金

Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state
控制脓毒症诱导的免疫麻痹状态的细胞和分子机制
  • 批准号:
    10557190
  • 财政年份:
    2020
  • 资助金额:
    $ 30.06万
  • 项目类别:
Evaluation of CC mice as an improved model for influenza immunity
CC 小鼠作为流感免疫改良模型的评估
  • 批准号:
    10117187
  • 财政年份:
    2020
  • 资助金额:
    $ 30.06万
  • 项目类别:
Differentiation of pathogen-specific memory CD8 T cell responses
病原体特异性记忆 CD8 T 细胞反应的分化
  • 批准号:
    9814211
  • 财政年份:
    2019
  • 资助金额:
    $ 30.06万
  • 项目类别:
Molecular mechanisms controlling differentiation of memory CD8 T cells
控制记忆CD8 T细胞分化的分子机制
  • 批准号:
    8949463
  • 财政年份:
    2015
  • 资助金额:
    $ 30.06万
  • 项目类别:
Impairment and recovery of CD8 T cell responses after sepsis
脓毒症后 CD8 T 细胞反应的受损和恢复
  • 批准号:
    9302800
  • 财政年份:
    2015
  • 资助金额:
    $ 30.06万
  • 项目类别:
Memory CD8 T cell localization and protection from influenza
记忆 CD8 T 细胞定位和流感保护
  • 批准号:
    9884079
  • 财政年份:
    2014
  • 资助金额:
    $ 30.06万
  • 项目类别:
Memory CD8 T cell localization and protection from influenza
记忆 CD8 T 细胞定位和流感保护
  • 批准号:
    10534144
  • 财政年份:
    2014
  • 资助金额:
    $ 30.06万
  • 项目类别:
Memory CD8 T cell localization and protection from influenza
记忆 CD8 T 细胞定位和流感保护
  • 批准号:
    10317045
  • 财政年份:
    2014
  • 资助金额:
    $ 30.06万
  • 项目类别:
Memory CD8 T cell localization and protection from influenza
记忆 CD8 T 细胞定位和流感保护
  • 批准号:
    10077814
  • 财政年份:
    2014
  • 资助金额:
    $ 30.06万
  • 项目类别:
Memory CD8 T cell localization and protection from influenza
记忆 CD8 T 细胞定位和流感保护
  • 批准号:
    8960855
  • 财政年份:
    2014
  • 资助金额:
    $ 30.06万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 30.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了